Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × XAV-19 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Severe Acute Respiratory Syndrome 1 Pneumonia 1 Lymphoma, Follicular 1 COVID-19 1

Interventions

Cisplatin 1281 Carboplatin 1195 Cyclophosphamide 1139 Gemcitabine 1043 Bevacizumab 1032 Paclitaxel 1025 Radiotherapy 1009 Docetaxel 942 pembrolizumab 874 Oxaliplatin 787 Capecitabine 769 Fluorouracil 722 Rituximab 630 Doxorubicin 568 Dexamethasone 565 Nivolumab 564 Etoposide 557 Irinotecan 541 Leucovorin 500 Pemetrexed 427 Drug Therapy 408 Cetuximab 404 Cytarabine 401 Trastuzumab 398 Filgrastim 377 Magnetic Resonance Spectroscopy 372 Prednisone 363 Lenalidomide 346 Bortezomib 342 Temozolomide 332

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04453384 2022-03-25

POLYCOR

Nantes University Hospital

Phase 2 Completed

COVID-19, Lymphoma, Follicular, Pneumonia, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡